Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GCA 2700® is a multi-ingredient dietary supplement developed by Santé Verte Laboratoires designed to support joint health, flexibility, and comfort. The formulation is a complex of six active ingredients: glucosamine sulfate and chondroitin sulfate, which are key structural components of cartilage; methylsulfonylmethane (MSM), which provides organic sulfur; turmeric extract (Curcuma longa), utilized for its role in maintaining tendon and joint flexibility; harpagophytum (devil's claw), used for mobility; and hyaluronic acid, a component of synovial fluid that supports joint lubrication. It is primarily indicated for individuals experiencing age-related joint issues or symptoms associated with arthritis. Clinical evaluations conducted by Mérieux Nutrisciences demonstrated that 84% of consumers reported satisfaction with the product after three months of use, as assessed by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GCA 2700.